JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M206743200 on July 22, 2002

J. Biol. Chem., Vol. 277, Issue 38, 35156-35161, September 20, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/38/35156    most recent
M206743200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mao, J.
Right arrow Articles by Wu, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mao, J.
Right arrow Articles by Wu, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Regulation of Gli1 Transcriptional Activity in the Nucleus by Dyrk1*

Junhao MaoDagger §, Peter MayeDagger , Priit Kogerman||, Francisco J. Tejedor**, Rune Toftgard, Wei XieDagger Dagger , Guanqing Wu§§, and Dianqing WuDagger ¶¶

From the Dagger  Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut 06030,  Karolinska Institutet, Department of Bioscience and Center for Nutrition and Toxicology, Novum, SE-141 57 Huddinge, Sweden, || National Institute of Chemical Physics and Biophysics and Center of Gene Technology, Tallinn Technical University, Tallinn, Estonia, ** Unidad de Neurobiologia del Desarrollo, Instituto de Neurociencias, Universidad Miguel Hernandezy CSIC, Campus de San Juan, 03550 Alicante, Spain, § Department of Pharmacology, University of Rochester, Rochester, New York 14642, Dagger Dagger  Department of Genetics, Southeast University Medical School, Nanjing, China, and §§ Department of Medicine/Genetic Medicine, Vanderbilt University, Nashville, Tennessee 37232

Received for publication, July 8, 2002, and in revised form, July 18, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

To investigate the cellular role of dual specificity Yak1-related kinase (Dyrk) 1, a nuclear localized dual specificity protein kinase, we examined its effect on transcriptional regulation using reporter gene assays. We found that Dyrk1 can substantially enhance Gli1-dependent, but not LEF-1-, c-Jun-, or Elk-dependent, gene transcription. In part, Dyrk1 does this through retaining Gli1 in the nucleus. However, we also demonstrate that Dyrk1 can enhance the transcriptional activity of Gli1-AHA, a nuclear export mutant, suggesting that Dyrk1 may be more directly involved in regulating the transcriptional activity of Gli1. In addition, Dyrk1 acted synergistically with Sonic hedgehog (Shh) to induce gene transcription and differentiation in mouse C3H10T1/2 cells. The failure of Shh to stimulate Dyrk1 kinase activity suggests that Dyrk1 may not be directly regulated by the Shh signaling pathway but functionally interacts with it. Thus, Gli1 transcriptional activity may be subjected to further regulation in the cell nucleus by a pathway distinct from Shh signaling, one mediated by Dyrk1.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The dual specificity Yak1-related kinase (Dyrk)1 gene family encodes for dual specificity kinases that can phosphorylate serine/threonine and tyrosine residues (1, 2). Dyrks are distant members of the mitogen-activated protein kinase family and also share sequence similarity to cyclin-dependent kinases (3). The Dyrk family in mammals consists of at least seven members, with four distinct classes of Dyrk kinases (Dyrk1-4) (2). However, an increasing number of Dyrk-like kinases also have been reported, including the homeodomain-interacting protein kinase family, androgen receptor protein kinase, and Myak (4-6).

Although the developmental importance of the Dyrk gene family remains largely unknown, studies with Yak1 in yeast and minibrain (mnb) in Drosophila suggest their involvement in regulating cell proliferation (7, 8). As the name suggests, mnb mutant flies have a smaller brain size as a result of a defect in neurogenesis (8). There is evidence in humans that the Dyrk1 class, a homolog of the Drosophila mnb gene, contains three separate genes, Dyrk1a, Dyrk1b, and Dyrk1c (9). Interestingly, Dyrk1a has been mapped to the Down's syndrome critical region of chromosome 21, and transgenic mice harboring an extra copy of this gene retain deficits in learning (10-12). This strongly suggests that the Dyrk1/mnb class has evolved a conserved role that is essential for proper brain development.

Cell transfection studies on GFP-tagged versions of Dyrk1a and homeodomain-interacting protein kinase 2 have confirmed their nuclear localization (2, 4). Interestingly, the staining pattern of GFP fluorescence in the nucleus has revealed that Dyrk1a and homeodomain-interacting protein kinase 2 associate with nuclear speckles, potential sites of alternative splicing or transcriptional regulation. Recently, studies with homeodomain-interacting protein kinase 2 have demonstrated its ability to associate with nuclear bodies, co-localize with PML3, and bind p53 and CREB-binding protein, revealing its role in transcriptional regulation (13, 14). Consistent with the idea that nuclear localized Dyrks may regulate transcriptional activity, many of the protein substrates identified in protein interactor screens involving Dyrk have been transcription factors. Biochemical studies with Dyrk1a have demonstrated its ability to interact with the transcription factors Forkhead, CREB, and signal transducers and activators of transcription 3 (15-17).

Cell transfection studies carried out in our laboratory have revealed that Dyrk1a can dramatically enhance the transcriptional activity of Gli1. Gli1, Gli2, and Gli3 are vertebrate homologs to the Drosophila cubitus interruptus (ci) gene, a five-zinc finger transcription factor whose function is highly regulated by the hedgehog signaling pathway (18-20). Hedgehog genes encode for secreted signaling proteins that can function as growth factor and morphogen important for cell proliferation and pattern formation (21-23). Analagous to Ci in Drosophila, Gli transcription factors are key downstream signaling components of the hedgehog pathway in vertebrates.

Increasing evidence suggests that Gli/Ci proteins are highly regulated in the cell cytoplasm and nucleus. In the absence of hedgehog signaling, Ci protein is retained in the cell cytoplasm as part of a protein complex associated with microtubules containing the negative regulators Costal2 and suppressor of fused (SuF) (24-27). Here full-length Ci protein is proteolytically processed into a shortened transcriptional repressor form (28, 29). In the presence of hedgehog signaling, full-length Ci protein is transported into the nucleus to activate hedgehog target genes (30). Once inside the nucleus, Gli transcription factor activity is still modulated by a number of different factors. CREB-binding protein, a general transcriptional co-activator, can directly bind Ci or Gli3 and is believed to enhance transcription in part through its acetylase activity (31-33). Recent biochemical data also suggest that SuF may associate with SAP18 and mSin3, forming a deacetlyase complex, resulting in Gli/Ci transcriptional repression (34).

In this report, we describe our findings that Dyrk1 activated Gli1-dependent gene transcription, but not LEF-1-, c-jun-, or Elk-dependent gene transcription. Dyrk1 does this by retaining Gli1 in the nucleus as well as by enhancing the transcriptional activity. In addition, we show that Dyrk1 functionally interacts with the Shh pathway to induce gene transcription and differentiation in C3H10T1/2 cells.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell Culture, Transfection, and Reporter Gene Assay-- NIH3T3 cells and Cos-7 cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal calf serum. C3H10T1/2 cells were cultured in minimum essential medium alpha  medium with 10% heat-inactivated fetal calf serum. Transfection was carried out using LipofectAMINE Plus as suggested by the manufacturer (Invitrogen). The transfection was stopped after 3 h, and cell extracts were collected 24 h later for luciferase assays, kinase assays, and Western analysis. Luciferase assays were performed using the Roche Molecular Biochemicals Luciferase Assay Kit as instructed. Cell lysates were first taken to determine the fluorescence intensity emitted by GFP in a Wallac multicounter, which is capable of counting fluorescence and luminescence. Then, luciferase substrate was added to the cell lysates, and luciferase activities were determined by measuring luminescence intensity using the same counter. Luminescence intensity was normalized against fluorescence intensity. DNA concentrations were adjusted if transfection of any of the cDNAs resulted in significant differences between normalized and non-normalized data.

Immunoprecipitation, Kinase Assay, and Western Analysis-- Immunoprecipitation and Western analysis were performed as described previously (35). For in vitro Dyrk kinase assay, Gli1-HA or its mutants and Dyrk1-HA were separately expressed in Cos-7 cells and immunoprecipitated by anti-HA antibodies. 24 h later, cells were lysed, and HA-tagged proteins were immunoprecipitated with an anti-HA antibody. The immunocomplexes were mixed and then divided into two portions. One portion was washed, separated by SDS-PAGE, and analyzed by Western blotting using an anti-HA antibody, and the other was incubated at 30 °C for 30 min in the presence of 10 µCi of [32P]ATP and 10 µM ATP. The kinase reactions were terminated by the addition of 4× SDS sample buffer, and the samples were separated by SDS-PAGE and visualized using a phosphorimager.

Immunofluorescence Staining-- NIH3T3 cells transfected with appropriate expression plasmids were fixed for 15 min in phosphate-buffered saline containing 2% paraformaldehyde, followed by permeabilization in phosphate-buffered saline containing 0.2% Triton X-100. HA-tagged Dyrk1 or Dyrk1KR was detected by immunofluorescence staining using a red fluorescent Alexis dye-conjugated anti-HA antibody, whereas the intracellular localization of GFP fusion proteins was directly visualized under a fluorescence microscope simultaneously. Nuclei were stained with Hoechst dye.

Alkaline Phosphatase Assay-- C3H10T1/2 cells were lysed 3 days after transfection. The cell lysates were mixed with the CDP-Star chemiluminescent substrate for alkaline phosphatase as instructed by the manufacturer (Tropix). After a 1-h incubation at room temperature, the luminescence intensity was measured using the Wallac multicounter.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effects of Dyrk1 and Mnb on Gene Transcription-- To investigate the possible involvement of Dyrk1 in gene transcriptional regulation, we examined the effects of Dyrk1 overexpression in a number of reporter gene assay systems. We found that co-expression of Dyrk1 and Gli1 strongly induced Gli1-dependent gene transcription in the presence of the 3'GliBS-Luc reporter construct, but not in the presence of the mutant reporter construct, m3'GliBS-Luc (Fig. 1A). The 3'GliBS-Luc reporter construct, as described previously (19), contains Gli DNA binding sequences through which the production of the reporter, luciferase, is regulated. In addition, we found that Dyrk1 enhanced the binding of Gli1 to its response element in an electrophoretic mobility shift assay (data not shown). The involvement of Dyrk1 in gene transcriptional regulation of Gli1 appears to be specific because expression of Dyrk1 did not activate Elk-, c-Jun-, or LEF-1-mediated gene transcription in NIH3T3 cells (Fig. 1, B-D). In addition, many other protein kinases, including mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, Src, and casein kinase Iepsilon , while stimulating Elk-, c-Jun-, and LEF-1-dependent gene transcription, respectively, failed to induce Gli1-dependent gene transcription (Fig. 1A). The Dyrk1 Drosophila homolog mnb, which shares 85% amino acid sequence homology with Dyrk1 in its kinase domain (1, 8), was also tested, and it was found to be a potent activator of Gli1 (Fig. 1A).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of the Dyrk kinases on gene transcription. NIH3T3 cells were co-transfected with (A) 0.1 µg of 3'GliBS-Luc reporter plasmid, 0.1 µg of enhanced GFP expression construct, and 0.2 µg of LacZ, Dyrk1, Mnb, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, Src, or casein kinase Iepsilon in the presence or absence of 0.1 µg of Gli1 expression constructs; (B-D) 0.15 µg of GFP expression construct, 0.2 µg of LacZ, Dyrk1, activated mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, activated Src protein kinase, or casein kinase Iepsilon (CKIepsilon ) and 0.15 µg of Elk-luciferase reporter plasmid (B), c-Jun-luciferase reporter plasmid (C), or LEF-luciferase reporter plasmid (D). LacZ expression plasmid was used to make the total amount of DNA equal (0.5 µg/well) in all transfections. 1 day later, cells were lysed, and GFP levels and luciferase activity were determined. The luciferase activities presented were normalized against the levels of GFP expression. Data show similar tendencies with or without normalization. Experiments were carried out in triplicates and repeated at least three times. The representative experiments are shown, and error bars represent S.D.s.

To determine whether activation of Gli1-dependent gene transcription by Dyrk1 depends on its kinase activity, we obtained a kinase-null mutant, Dyrk1KR, which contains a Lys-188 to Arg point mutation at the ATP binding region of its kinase domain. Unlike wild-type Dyrk1, this kinase-deficient mutant did not show any synergistic effect with Gli1 (Fig. 2A). In addition, activation of Gli1-mediated gene transcription seems to be independent of Dyrk1 C-terminal sequences because deletion of C-terminal residues 498-763 located after the kinase domain did not affect its capacity to induce Gli1-dependent gene transcription (data not shown).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Dyrk-induced transcriptional activity depends on Dyrk kinase activity and Gli target sequence. A, NIH3T3 cells were transfected with 0.1 µg of 3'GliBS-Luc or m3'GliBS-Luc reporter plasmid, 0.1 µg of enhanced GFP expression construct, and 0.1 µg of Gli1 expression plasmid in the presence or absence of 0.2 µg of Dyrk1 or Dyrk1KR expression constructs. The luciferase activity was determined and presented as described in Fig. 1. B and C, the expression levels of Gli1, Dyrk1, and Dyrk1KR were determined using Western analysis with anti-myc or anti-HA antibodies that recognize myc-tagged Gli1 or HA-tagged Dyrk. Tyrosine phosphorylation of Dyrk1 was detected by an anti-phosphotyrosine antibody.

Dyrk1 Regulates Gli1 Nuclear Export-- Regulation of Ci proteolysis has been proposed as a mechanism for regulation of its transcriptional activity (36). Because there are no significant changes in the levels of full-length Gli1 protein when Gli1 and Dyrk1 were co-expressed (Fig. 2B), the processing of Gli1 protein may not play an important role in Dyrk1-mediated Gli1 activation. In the past several years, it has been reported that regulation of nuclear trafficking represents a novel mechanism for the control of the activities of gene transcriptional regulators (37). Two recent studies (38, 39) as well as our data (see below) demonstrate that Gli1 and Ci are nuclear shuttling proteins. Hedgehog signaling appears to regulate the import of Ci (38). In addition, vertebrate Su(fu), a homolog of the Drosophila hegdgehog signaling protein suppressor of fused, binds to Gli proteins (25, 39) and may retard Gli1 nuclear import (39, 42). We investigated whether Dyrk1, which is localized in the nucleus (2), has any effect on the subcellular localization of Gli1. To determine the intracellular localization of Gli1, we constructed the expression plasmid Gli1-GFP. The intracellular localization of Gli1-GFP fusion protein was visualized under fluorescence in the presence or absence of Dyrk1-HA. Dyrk1-HA and nuclei were visualized after Gli1-GFP in the same cell and stained with red fluorescent Alexis dye-conjugated anti-HA antibody and Hoechst dye, respectively. Consistent with previous reports (9, 39), Dyrk1 and its mutant, Dyrk1KR, were primarily localized in the nucleus (Fig. 3, E and H), whereas the Gli1 protein was predominantly localized in the cytoplasm in the absence of co-expressed Dyrk1 (Fig. 3A). However, co-expression of Dyrk1-HA caused significant accumulation of Gli1-GFP in the nucleus (Fig. 3D). More importantly, Dyrk1-mediated nuclear accumulation of Gli1-GFP protein depended on Dyrk1 kinase activity because Dyrk1KR could not induce nuclear accumulation of Gli1 protein (Fig. 3G). The levels of Gli1 in the nuclear fraction from cells expressing Dyrk1 were also found to be higher than those from cells expressing control protein beta -galactosidase (data not shown).


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 3.   Regulation of nuclear transport of Gli1 by Dyrk1. NIH3T3 cells were transfected with Gli1-GFP (A and B) or GFP (C) or co-transfected with Gli1-GFP and Dyrk1-HA (D-F) or Gli1-GFP and DyrkKR-HA (G-I). Localization of Gli1-GFP or GFP was detected by green fluorescence (A, C, D, and G), and co-expressed HA-tagged Dyrk1 was visualized in the same cell by immunofluorescence staining with red Alexis dye-conjugated anti-HA antibodies (E and H), whereas the nucleus was visualized by Hoechst staining (B, F, and I).

Dyrk1 Phosphorylates Gli1-- Phosphorylation has recently emerged as a major mechanism for regulating protein nuclear transport (37). Because Dyrk1 kinase activity is essential for Gli1 nuclear retention, we wanted to know whether Dyrk1 could phosphorylate Gli1 protein, and which domains might be phosphorylated. Gli1-HA or its truncated mutants (Fig. 4A) and Dyrk1-HA were separately expressed in Cos-7 cells and immunoprecipitated by anti-HA antibodies. Then the immunocomplexes were mixed in the presence of [32P]ATP. Significant phosphorylation of Gli1-HA, Gli1N-HA, and Gli1C-HA, but not Gli1ZF-HA, was observed in the presence of Dyrk1 (Fig. 4B). No phosphorylation was detected in the absence of Dyrk1 (Fig. 4B) or in the presence of Dyrk1KR (data not shown). Although Dyrk1 is a dual specificity kinase, the phosphorylation of Gli1 by Dyrk1 appeared to be predominantly on Ser/Thr residues because we could not detect phosphotyrosines in Dyrk1-treated Gli1 or its mutants by Western analysis using an anti-phosphotyrosine antibody (data not shown). However, we were able to detect Dyrk1 autophosphorylation by using the same anti-phosphotyrosine antibody (Fig. 2C). A previous report has demonstrated that tyrosine autophosphorylation of Dyrk1 is required for its kinase activity (1). These results, together with the observation that Dyrk1-mediated nuclear accumulation of Gli1 depends on its kinase activity, suggest that Dyrk1 may regulate nuclear transport of Gli proteins via phosphorylation.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 4.   Phosphorylation of Gli1 by Dyrk1. A, schematic representation of Gli1 and Gli1 mutants. Some Gli1 structural motifs, including zinc finger (ZF), nuclear localization signal (NLS), NES, and transcriptional activation domain (TAD), are denoted. B, Cos-7 cells were transfected with Gli1-HA, its mutants, Dyrk1-HA, or Dyrk1KR-HA expression plasmids. 24 h later, cells were lysed, and HA-tagged proteins were immunoprecipitated with an anti-HA antibody. The immunocomplexes were mixed and then divided into two portions. One was incubated with [32P]ATP for in vitro kinase assay, and the other was washed, separated by SDS-PAGE, and analyzed by Western blotting using an anti-HA antibody.

Dyrk1 phosphorylates both the N-terminal and C-terminal portions of Gli1. To determine which portions of Gli1 are required for Dyrk1-mediated nuclear retention, two Gli1 mutants, Gli1Delta N-GFP (amino acids 195-1107) and Gli1Delta C-GFP (amino acids 1-410), were generated, and the intracellular localization was determined in the presence or absence of co-expressed Dyrk1. We found that both Gli1Delta N-GFP and Gli1Delta C-GFP were predominantly localized in the cytoplasm despite the presence of Dyrk1. However, we noticed that Gli1Delta C-GFP was detected in the nuclei of a small fraction of cells that co-express both Gli1Delta C-GFP and Dyrk1 (data not shown). Nevertheless, we believe that both the N-terminal and C-terminal portions of Gli1 are important for efficient nuclear retention of Gli1 by Dyrk1.

Dyrk1 Stimulates Transcriptional Activity of Gli1-- With the knowledge that Dyrk1 phosphorylates and retains Gli1 protein in the nucleus, the next question is whether nuclear retention of Gli1 is the sole mechanism for Dyrk1-induced Gli-dependent transcriptional activation. To address this question, we generated another Gli1 mutant, called Gli1-AHA-GFP, in which three amino acids (Leu-Arg-Leu) in the core tetramer of the nuclear export sequence (NES) were changed to Ala-His-Ala (Fig. 5A). As we expected, this mutant accumulated in the nucleus independently of Dyrk1 (Fig. 5B). This result further confirmed that Gli1 NES is involved in Gli1 export, probably by interacting with the nuclear export receptor Crm1 (46). The transcriptional activity of Gli1-AHA was determined using the 3'GliBS-Luc reporter assay. We found that Gli1-AHA showed a higher basal transcriptional activity than the wild-type Gli1 (Fig. 5C). This augmented basal activity is probably due to the increased accumulation of Gli mutant proteins in the nucleus. The fact that basal activity of Gli1-AHA is less than the activity of the wild-type Gli1 in the presence of Dyrk1 and that Gli1-AHA can be further stimulated by co-expressed Dyrk1 suggests that Dyrk1 can also stimulate the transcriptional activity of Gli1 in addition to retaining Gli1 in the nucleus. The expression levels of wild-type Dyrk1 and its AHA mutant are shown in Fig. 5D.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 5.   Dyrk1 stimulates the transcriptional activity of Gli1. A, schematic representation of the Gli1 molecule and Gli1 mutants. B, nuclear localization of Gli1-AHA mutant expressed in NIH3T3 cells. C, transcriptional activity of Gli1-AHA. Transfection of NIH3T3 cells was carried out, and luciferase activity was determined and presented as described in the Fig. 1 legend. D, the expression levels of wild-type Gli1 and its AHA mutant.

Dyrk1 Interacts with the Shh Signaling Pathway-- In the presence of hedgehog signaling, increased levels of Gli/Ci proteins get imported into the nucleus and activate downstream target genes (36, 47). Therefore, we wanted to know whether Dyrk1 could potentiate a Gli response in cells undergoing Shh signaling. It was previously shown that Shh could induce Gli-dependent transcriptional activation of the 3'GliBS-Luc reporter gene and differentiation in C3H10T1/2 embryonic fibroblast cells (48). Consistent with previous reports, when C3H10T1/2 cells were co-transfected with cDNA encoding Shh and 3'GliBS-Luc reporter gene, the cells produced more luciferase activity than cells transfected with 3'GliBS-Luc reporter gene alone (Fig. 6A). Co-expression of Dyrk1 with Shh further increases reporter gene activity, which is more than the sum of those in cells expressing Dyrk1 or Shh alone, suggesting that Shh and Dyrk1 acted synergistically. The effect of Dyrk1 on Shh-induced differentiation of C3H10T1/2 cells was also examined by assaying changes in alkaline phosphatase activity as described previously (48, 49). Again, co-expression of Dyrk1 with Shh demonstrated a synergistic effect, this time in stimulating alkaline phosphatase activity (Fig. 6B).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 6.   Functional interaction between Dyrk1 and the Shh signaling pathway. A, Shh acted synergistically with Dyrk1 to induce gene transcription in C3H10T1/2 cells. C3H10T1/2 cells were co-transfected with 0.1 µg of 3'GliBS-Luc reporter plasmid, 0.15 µg of GFP expression construct, and 0.125 µg of mouse Shh expression plasmid or 0.125 µg of Gli1 expression plasmid with or without 0.125 µg of Dyrk1 or Dyrk1KR. LacZ expression plasmid was used to make the total amount of DNA equal (0.5 µg/well) in all transfections. Luciferase assays were carried out 3 days after transfection, and the data were processed and presented as described in the Fig. 1 legend. B, Dyrk1 acted synergistically with Shh and Gli1 to induce differentiation of C3H10T1/2 cells. C3H10T1/2 cells were transfected with 0.25 µg of Dyrk1 and 0.25 µg of LacZ, mouse Shh, or Gli1. The alkaline phosphatase (AP) activities were determined 3 days after transfection. C, Dyrk1KR failed to inhibit Shh effect. C3H10T1/2 cells were transfected as described in B, except that wild-type Dyrk1 was replaced with varying amounts of Dyrk1KR. LacZ expression plasmid was used to make the total amount of DNA equal (0.5 µg/well) in all transfections. D, tyrosine phosphorylation of Dyrk1. C3H10T1/2 cells were transfected with 0.25 µg of Dyrk1 and 0.25 µg of LacZ or Shh. Dyrk-HA was precipitated using antibodies specific to HA. The immunocomplexes were detected with anti-HA and anti-phosphotyrosine antibodies, respectively.

To determine whether the Shh-activated pathway directly regulates Dyrk1, we examined whether Shh could stimulate Dyrk1 phosphorylation. Dyrk1 was immunoprecipitated from cells expressing Dyrk1 alone or from cells co-expressing Dyrk and Shh. The phosphotyrosine content of precipitated Dyrk was detected using a phosphotyrosine-specific antibody. Shh did not stimulate phosphorylation of Dyrk (Fig. 6D). In agreement with this, the Dyrk kinase-deficient mutant did not inhibit Shh-induced production of alkaline phosphatase in C3H10T1/2 cells (Fig. 6C). Thus, Dyrk does not appear to be directly regulated by Shh.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In this study, we provide biochemical evidence that Dyrk1, a nuclear protein kinase, and its Drosophila homolog mnb can enhance the transcriptional activity of Gli1. In part, this increase in transcriptional activity is a result of elevated Gli1 protein levels in the nucleus. However, the ability of Dyrk1 to induce transcriptional activity of Gli1-AHA, a nuclear export mutant, also suggests that Dyrk1 may be more directly involved in modulating Gli1 transcriptional activity. We also show that Gli1 is phosphorylated in the presence of Dyrk1 and that Dyrk1 kinase activity is essential for Gli1 nuclear retention and its increased transcriptional activity. In addition, Dyrk1 can synergistically function with Shh to stimulate Gli reporter gene activity and differentiate C3H10T1/2 cells.

Nuclear cytoplasmic trafficking has been shown to be one mechanism by which transcription factor function can be modulated (37). Previous work on Gli/Ci, as well as our work presented here, has demonstrated that Gli/Ci proteins are nuclear cytoplasmic shuttling proteins. The nuclear export of Gli1/Ci appears to depend on Crm1, a nuclear export receptor, because the typical NES sequences are required for export (Fig. 5A) and can be blocked by leptomycin B (39) (data not shown). Chen et al. (38) showed that regulation of nuclear-cytoplasmic transport might be one mechanism used by Hh to regulate Ci. Hh may not only prevent Ci from proteolytic cleavage but may also increase levels of Ci in the nucleus by promoting its nuclear import.

Phosphorylation has been shown to have different effects on the interactions between shuttling proteins and Crm1. Phosphorylation of MK2 at a specific site was shown to unmask the NES, thus facilitating binding to Crm1 and stimulating its nuclear export (50), whereas phosphorylation at serine residues in the NES of cyclin B blocked binding to Crm1 and inhibited its nuclear export (45). In this report, we showed that overexpression of Dyrk1, a nuclear localized kinase, led to the accumulation of Gli1 in the nucleus. We also showed that Dyrk1 kinase activity is necessary for Gli1 nuclear retention and that Gli1 is phosphorylated at multiple sites in the presence of Dyrk1 (Fig. 4). Therefore, one potential mechanism by which Dyrk1 can regulate Gli1 function is by regulating its nuclear export through phosphorylation.

However, the accumulation of Gli1 in the nucleus as a result of Dyrk1 kinase activity could also be from an increase in protein-protein interactions. In support of this idea, recent work has shown that co-expression of Zic proteins, nuclear localized transcription factors, with members of the Gli family also results in accumulation of Gli proteins in the nucleus (44). Our studies demonstrate that Dyrk1 kinase activity does more than retain Gli1 in the nucleus-it also stimulates Gli1 transcriptional activity. Reporter gene studies in which Dyrk1 and Gli1-AHA were co-expressed clearly show that Gli1 transcriptional activity can be further enhanced by Dyrk1. This suggests that Dyrk1 may be more directly involved in modulating the transcriptional activity of Gli1 in the nucleus. Therefore, it is possible that Dyrk1 phosphorylation of Gli1 results in more efficient association of Gli1 with other transcriptional cofactors, thus delaying its nuclear export.

Consistent with our observation that Dyrk1 can stimulate Gli1 transcriptional activity, previous work on Dyrk1 has suggested that it may also regulate the function of other transcription factors such as CREB, Forkhead, and signal transducers and activators of transcription 3 (15-17). There is also evidence that homeodomain-interacting protein kinase 2, a Dyrk-like kinase, can bind p53 and CREB-binding protein to enhance transcription (13, 14). Collectively, these studies provide increasing evidence that one possible role of nuclear localized Dyrk kinases may be to modulate transcription factor function. However, how specific or general a role remains to be determined.

The distinct effect of Hh and Dyrk on the nuclear transport of the Ci/Gli proteins suggests that Dyrk1 may not be a direct signaling component within the Hh pathway. This is consistent with our observations that Shh did not stimulate phosphorylation of Dyrk1 and that the kinase-deficient mutant of Dyrk1 could not inhibit Shh-induced effects in C3H10T1/2 cells. However, the synergistic effect between Dyrk1 and Shh in enhancing Gli-dependent gene transcription and increasing alkaline phosphatase activity in C3H10T1/2 cells suggests that these two pathways may functionally interact. Although Dyrk1 is not essential for Hh signaling, levels of Dyrk1 kinase activity in the nucleus may determine how robust cells respond to Hh signaling. Thus, Gli/Ci proteins may be the cellular targets for at least two distinct signaling pathways: one regulated by the Hh proteins in the cytoplasm, and the other mediated by the Dyrk kinases in the nucleus.

The inability of Shh to stimulate Dyrk1 phosphorylation still leaves the following question: what regulates Dyrk kinase activity? Similar to mitogen-activated protein kinases, Dyrks contain an activation loop within the catalytic domain (2). Therefore, early studies hypothesized that Dyrk activation may be analogous to mitogen-activated protein kinase activation, via phosphorylation by an upstream kinase (1). However, recent transfection studies in mammalian cells favor the possibility that, unlike mitogen-activated protein kinases, Dyrk1 can activate itself through auto-phosphorylation (43). This may explain why overexpression of Dyrk1 alone results in vigorous kinase activity. It is also interesting to speculate that if Dyrk1a can activate itself through autophosphorylation, then gene dosage and transcriptional control may be important regulatory mechanisms. Another possibility is that Dyrk, like glycogen synthase kinase 3, might be negatively regulated by yet unknown upstream kinases or even phosphatases.

Developmental studies of the Dyrk1/mnb class of Dyrk kinases suggest an important role in proper brain development. Mutations in the Drosophila mnb gene that cause a reduction protein expression were associated with defects in neuroblast proliferation and specific behavioral abnormalities (8). The mammalian homolog of mnb, Dyrk1a, has been mapped to the Down's syndrome critical region of chromosome 21, and transgenic mice retaining an extra copy of Dyrk1 have learning deficits (10-12). Several studies have also demonstrated the involvement of the Hh-Gli signaling pathway in neuronal proliferation (47). In the vertebrate central nervous system, Shh acts as a mitogen for a number of neuronal precursor cells, including those located in the spinal cord and retina, oligodendrocyte cell precursors in the neural tube, and granule neuronal cell precursors in the cerebellum (40, 41, 47). Studies on the hedgehog receptor Patched1 also reveal the importance of repressing the Hh pathway during brain development. Loss of function mutations in Patched1, which aberrantly activates hedgehog signaling, result in overproliferation of granule cell precursors in the cerebellum (41). Because Hh and Dyrk1/mnb pathways are important for central nervous system development, it is interesting to speculate whether or not both these pathways interact with each other during neuronal development in vivo. Future studies will focus on the potential for Hh and Dyrk1 pathways to interact with each other during neuronal development through modulating Gli transcriptional activity.

    ACKNOWLEDGEMENTS

We thank Walter Becker and Hans-Georg Joost for Dyrk cDNAs, Kenneth W. Kinzler and Bert Vogelstein for Gli1, Dr. Hiroshi Sasaki for the 3'GliBS-Luc and m3'GliBS-Luc reporter constructs, Owen Witte for Src, and Rudolf Grosschedl for LEF-1 expression plasmid and reporter construct. We also thank Yan Yang for generous support and helpful discussion and Anne Paxhia for technical help.

    FOOTNOTES

* This work was supported by grants from the National Institutes of Health and American Cancer Society and by American Heart Association Established Investigator Award (to D. W.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¶¶ To whom correspondence should be addressed: Dept. of Genetics and Developmental Biology, University of Connecticut Health Center, MC3301, 263 Farmington Ave., Farmington, CT 06030. Tel.: 860-679-8818; Fax: 860-679-8345; E-mail: dwu@neuron.uchc.edu.

Published, JBC Papers in Press, July 22, 2002, DOI 10.1074/jbc.M206743200

    ABBREVIATIONS

The abbreviations used are: Dyrk, dual specificity Yak1-related kinase; Shh, Sonic hedgehog; NES, nuclear export sequence; GFP, green fluorescent protein; CREB, cAMP-response element-binding protein; HA, hemagglutinin; LEF, lymphoid enhancer factor; Luc, luciferase; Hh, hedgehog.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Kentrup, H., Becker, W., Heukelbach, J., Wilmes, A., Schurmann, A., Huppertz, C., Kainulainen, H., and Joost, H. G. (1996) J. Biol. Chem. 271, 3488-3495[Abstract/Free Full Text]
2. Becker, W., and Joost, H. G. (1999) Prog. Nucleic Acid Res. Mol. Biol. 62, 1-17[Medline] [Order article via Infotrieve]
3. Miyata, Y., and Nishida, E. (1999) Biochem. Biophys. Res. Commun. 266, 291-295[CrossRef][Medline] [Order article via Infotrieve]
4. Kim, Y. H., Choi, C. Y., Lee, S. J., Conti, M. A., and Kim, Y. (1998) J. Biol. Chem. 273, 25875-25879[Abstract/Free Full Text]
5. Moilanen, A. M., Karvonen, U., Poukka, H., Janne, O. A., and Palvimo, J. J. (1998) Mol. Biol. Cell 9, 2527-2543[Abstract/Free Full Text]
6. Shang, E., Wang, X., Huang, J., Yoshida, W., Kuroiwa, A., and Wolgemuth, D. J. (2000) Mol. Reprod. Dev. 55, 372-378[CrossRef][Medline] [Order article via Infotrieve]
7. Hartley, A. D., Ward, M. P., and Garrett, S. (1994) Genetics 136, 465-474[Abstract]
8. Tejedor, F., Zhu, X. R., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., Heisenberg, M., Fischbach, K. F., and Pongs, O. (1995) Neuron 14, 287-301[CrossRef][Medline] [Order article via Infotrieve]
9. Becker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F. J., and Joost, H. G. (1998) J. Biol. Chem. 273, 25893-25902[Abstract/Free Full Text]
10. Song, W. J., Sternberg, L. R., Kasten-Sportes, C., Keuren, M. L., Chung, S. H., Slack, A. C., Miller, D. E., Glover, T. W., Chiang, P. W., Lou, L., and Kurnit, D. M. (1996) Genomics 38, 331-339[CrossRef][Medline] [Order article via Infotrieve]
11. Shindoh, N., Kudoh, J., Maeda, H., Yamaki, A., Minoshima, S., Shimizu, Y., and Shimizu, N. (1996) Biochem. Biophys. Res. Commun. 225, 92-99[CrossRef][Medline] [Order article via Infotrieve]
12. Altafaj, X., Dierssen, M., Baamonde, C., Marti, E., Visa, J., Guimera, J., Oset, M., Gonzalez, J. R., Florez, J., Fillat, C., and Estivill, X. (2001) Hum. Mol. Genet. 10, 1915-1923[Abstract/Free Full Text]
13. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G., Piaggio, G., Fanciulli, M., Appella, E., and Soddu, S. (2002) Nat. Cell. Biol. 4, 11-19[CrossRef][Medline] [Order article via Infotrieve]
14. Hofmann, T. G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., and Schmitz, M. L. (2002) Nat. Cell. Biol. 4, 1-10[CrossRef][Medline] [Order article via Infotrieve]
15. Woods, Y. L., Rena, G., Morrice, N., Barthel, A., Becker, W., Guo, S., Unterman, T. G., and Cohen, P. (2001) Biochem. J. 355, 597-607[CrossRef][Medline] [Order article via Infotrieve]
16. Yang, E. J., Ahn, Y. S., and Chung, K. C. (2001) J. Biol. Chem. 276, 39819-39824[Abstract/Free Full Text]
17. Matsuo, R., Ochiai, W., Nakashima, K., and Taga, T. (2001) J. Immunol. Methods 247, 141-151[CrossRef][Medline] [Order article via Infotrieve]
18. Von Ohlen, T., and Hooper, J. E. (1997) Mech. Dev. 68, 149-156[CrossRef][Medline] [Order article via Infotrieve]
19. Sasaki, H., Hui, C., Nakafuku, M., and Kondoh, H. (1997) Development 124, 1313-1322[Abstract]
20. Aza-Blanc, P., and Kornberg, T. B. (1999) Trends Genet. 15, 458-462[CrossRef][Medline] [Order article via Infotrieve]
21. Hammerschmidt, M., Brook, A., and McMahon, A. P. (1997) Trends Genet. 13, 14-21[CrossRef][Medline] [Order article via Infotrieve]
22. Ingham, P. W., and McMahon, A. P. (2001) Genes Dev. 15, 3059-3087[Free Full Text]
23. McMahon, A. P. (2000) Cell 100, 185-188[CrossRef][Medline] [Order article via Infotrieve]
24. Stone, D. M., Murone, M., Luoh, S., Ye, W., Armanini, M. P., Gurney, A., Phillips, H., Brush, J., Goddard, A., de Sauvage, F. J., and Rosenthal, A. (1999) J. Cell Sci. 112, 4437-4448[Abstract]
25. Pearse, R. V., II, Collier, L. S., Scott, M. P., and Tabin, C. J. (1999) Dev. Biol. 212, 323-336[CrossRef][Medline] [Order article via Infotrieve]
26. Monnier, V., Dussillol, F., Alves, G., Lamour-Isnard, C., and Plessis, A. (1998) Curr. Biol. 8, 583-586[CrossRef][Medline] [Order article via Infotrieve]
27. Methot, N., and Basler, K. (2000) Development 127, 4001-4010[Abstract]
28. Muller, B., and Basler, K. (2000) Development 127, 2999-3007[Abstract]
29. Price, M. A., and Kalderon, D. (2002) Cell 108, 823-835[CrossRef][Medline] [Order article via Infotrieve]
30. Wang, Q. T., and Holmgren, R. A. (2000) Development 127, 3131-3139[Abstract]
31. Akimaru, H., Chen, Y., Dai, P., Hou, D. X., Nonaka, M., Smolik, S. M., Armstrong, S., Goodman, R. H., and Ishii, S. (1997) Nature 386, 735-738[CrossRef][Medline] [Order article via Infotrieve]
32. Chen, Y., Goodman, R. H., and Smolik, S. M. (2000) Mol. Cell. Biol. 20, 1616-1625[Abstract/Free Full Text]
33. Dai, P., Akimaru, H., Tanaka, Y., Maekawa, T., Nakafuku, M., and Ishii, S. (1999) J. Biol. Chem. 274, 8143-8152[Abstract/Free Full Text]
34. Cheng, S. Y., and Bishop, J. M. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5442-5447[Abstract/Free Full Text]
35. Mao, J., Xie, W., Yuan, H., Simon, M. I., Mano, H., and Wu, D. (1998) EMBO J. 17, 5638-5646[CrossRef][Medline] [Order article via Infotrieve]
36. Ingham, P. W. (1998) EMBO J. 17, 3505-3511[CrossRef][Medline] [Order article via Infotrieve]
37. Hood, J. K., and Silver, P. A. (1999) Curr. Opin. Cell Biol. 11, 241-247[CrossRef][Medline] [Order article via Infotrieve]
38. Chen, C. H., von Kessler, D. P., Park, W., Wang, B., Ma, Y., and Beachy, P. A. (1999) Cell 98, 305-316[CrossRef][Medline] [Order article via Infotrieve]
39. Kogerman, P., Grimm, T., Kogerman, L., Krause, D., Unden, A. B., Sandstedt, B., Toftgard, R., and Zaphiropoulos, P. G. (1999) Nat. Cell. Biol. 1, 312-319[CrossRef][Medline] [Order article via Infotrieve]
40. Rowitch, D. H., St.-, Jacques, B., Lee, S., Flax, J. D., Snyder, E. Y., and McMahon, A. P. (1999) Development 19, 8954-8965
41. Wechsler-Reya, R. J., and Scott, M. P. (1999) Neuron 22, 103-114[CrossRef][Medline] [Order article via Infotrieve]
42. Ding, Q., Fukami, S., Meng, X., Nishizaki, Y., Zhang, X., Sasaki, H., Dlugosz, A., Nakafuku, M., and Hui, C.-C. (2000) Curr. Biol. 9, 1119-1122
43. Himpel, S., Panzer, P., Eirmbter, K., Czajkowska, H., Sayed, M., Packman, L. C., Blundell, T., Kentrup, H., Grotzinger, J., Joost, H. G., and Becker, W. (2001) Biochem. J. 359, 497-505[CrossRef][Medline] [Order article via Infotrieve]
44. Koyabu, Y., Nakata, K., Mizugishi, K., Aruga, J., and Mikoshiba, K. (2001) J. Biol. Chem. 276, 6889-6892[Abstract/Free Full Text]
45. Yang, J., Bardes, E. S., Moore, J. D., Brennan, J., Powers, M. A., and Kornbluth, S. (1998) Genes Dev. 12, 2131-2143[Abstract/Free Full Text]
46. Ullman, K. S., Powers, M. A., and Forbes, D. J. (1997) Cell 90, 967-970[CrossRef][Medline] [Order article via Infotrieve]
47. Altaba, A. R. I. (1999) Trends Genet. 15, 418-425[CrossRef][Medline] [Order article via Infotrieve]
48. Murone, M., Rosenthal, A., and de Sauvage, F. J. (1999) Curr. Biol. 9, 76-84[CrossRef][Medline] [Order article via Infotrieve]
49. Kinto, N., Iwamoto, M., Enomoto-Iwamoto, M., Noji, S., Ohuchi, H., Yoshioka, H., Kataoka, H., Wada, Y., Yuhao, G., Takahashi, H. E., Yoshiki, S., and Yamaguchi, A. (1997) FEBS Lett. 404, 319-323[CrossRef][Medline] [Order article via Infotrieve]
50. Engel, K., Kotlyarov, A., and Gaestel, M. (1998) EMBO J. 17, 3363-3371[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Shimokawa, U. Tostar, M. Lauth, R. Palaniswamy, M. Kasper, R. Toftgard, and P. G. Zaphiropoulos
Novel Human Glioma-associated Oncogene 1 (GLI1) Splice Variants Reveal Distinct Mechanisms in the Terminal Transduction of the Hedgehog Signal
J. Biol. Chem., May 23, 2008; 283(21): 14345 - 14354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Eichberger, A. Kaser, C. Pixner, C. Schmid, S. Klingler, M. Winklmayr, C. Hauser-Kronberger, F. Aberger, and A.-M. Frischauf
GLI2-specific Transcriptional Activation of the Bone Morphogenetic Protein/Activin Antagonist Follistatin in Human Epidermal Cells
J. Biol. Chem., May 2, 2008; 283(18): 12426 - 12437.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. W. Neill, W. J. Harrison, M. S. Ikram, T. D.L. Williams, L. S. Bianchi, S. K. Nadendla, J. L. Green, L. Ghali, A.-M. Frischauf, E. A. O'Toole, et al.
GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes
Carcinogenesis, April 1, 2008; 29(4): 738 - 746.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
M. F. Burkart, J. D. Wren, J. I. Herschkowitz, C. M. Perou, and H. R. Garner
Clustering microarray-derived gene lists through implicit literature relationships
Bioinformatics, August 1, 2007; 23(15): 1995 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Lauth, A. Bergstrom, T. Shimokawa, and R. Toftgard
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
PNAS, May 15, 2007; 104(20): 8455 - 8460.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Alvarez, X. Altafaj, S. Aranda, and S. de la Luna
DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via 14-3-3 Binding
Mol. Biol. Cell, April 1, 2007; 18(4): 1167 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. A. Kelly and Z. Rahmani
DYRK1A Enhances the Mitogen-activated Protein Kinase Cascade in PC12 Cells by Forming a Complex with Ras, B-Raf, and MEK1
Mol. Biol. Cell, August 1, 2005; 16(8): 3562 - 3573.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
V. Nguyen, A. L. Chokas, B. Stecca, and A. R. i Altaba
Cooperative requirement of the Gli proteins in neurogenesis
Development, July 15, 2005; 132(14): 3267 - 3279.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Di Marcotullio, E. Ferretti, E. De Smaele, B. Argenti, C. Mincione, F. Zazzeroni, R. Gallo, L. Masuelli, M. Napolitano, M. Maroder, et al.
RENKCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma
PNAS, July 20, 2004; 101(29): 10833 - 10838.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. H. Sitz, M. Tigges, K. Baumgartel, L. G. Khaspekov, and B. Lutz
Dyrk1A Potentiates Steroid Hormone-Induced Transcription via the Chromatin Remodeling Factor Arip4
Mol. Cell. Biol., July 1, 2004; 24(13): 5821 - 5834.
[Abstract] [Full Text] [PDF]


Home page